Search

Author/Creator Spiessens, Bart

1. 120. Safety, Reactogenicity, and Immunogenicity of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60–85 Years in a Randomized, Multicenter, Interventional, First-In-Human, Phase 1/2a Study. (15th December 2022)

Authors:
Doua, Joachim; Fierro, Carlos; Sarnecki, Michal; Spiessens, Bart; Go, Oscar; Davies, Todd; van den Dobbelsteen, Germie; Poolman, Jan; Haazen, Wouter
Journal:
Open forum infectious diseases
Issue:
Volume 9:(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A predictive enrichment procedure to identify potential responders to a new therapy for randomized, comparative controlled clinical studies. Issue 3 (21st December 2015)

Authors:
Li, Junlong; Zhao, Lihui; Tian, Lu; Cai, Tianxi; Claggett, Brian; Callegaro, Andrea; Dizier, Benjamin; Spiessens, Bart; Ulloa‐Montoya, Fernando; Wei, Lee‐Jen
Journal:
Biometrics
Issue:
Volume 72:Issue 3(2016)
Page Start:
877
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Characterization of Escherichia coli isolates potentially covered by ExPEC4V and ExPEC10V, that were collected from post-transrectal ultrasound-guided prostate needle biopsy invasive urinary tract and bloodstream infections. Issue 33 (14th July 2020)

Authors:
Saade, Elie; Gravenstein, Stefan; Donskey, Curtis J.; Wilson, Brigid; Spiessens, Bart; Abbanat, Darren; Poolman, Jan; de Palacios, Patricia Ibarra; Hermans, Peter
Journal:
Vaccine
Issue:
Volume 38:Issue 33(2020)
Page Start:
5100
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Distribution of extraintestinal pathogenic Escherichia coli O-serotypes and antibiotic resistance in blood isolates collected from patients in a surveillance study in Japan. Issue 11 (November 2022)

Authors:
Matsumoto, Tetsuya; Mikamo, Hiroshige; Ohge, Hiroki; Yanagihara, Katsunori; Weerdenburg, Eveline; Go, Oscar; Spiessens, Bart; van Geet, Gunter; van den Hoven, Thijs; Momose, Atsushi; Hagiwara, Yosuke; Nakayama, Yoshikazu; Poolman, Jan; Geurtsen, Jeroen; Kaku, Mitsuo
Journal:
Journal of infection and chemotherapy
Issue:
Volume 28:Issue 11(2022)
Page Start:
1445
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Gene expression of MAGE‐A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non–small cell lung cancer patients. Issue 5 (12th August 2016)

Authors:
Pan, Szu‐Hua; Su, Kang‐Yi; Spiessens, Bart; Kusuma, Nicole; Delahaye, Nicolas F; Gruselle, Olivier; Myo, Aung; de Creus, An; Louahed, Jamila; Chang, Gee‐Cheng; Yu, Sung‐Liang; Yang, Pan‐Chyr
Journal:
Asia-Pacific journal of clinical oncology
Issue:
Volume 13:Issue 5(2017)
Page Start:
e212
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Global Distribution of O Serotypes and Antibiotic Resistance in Extraintestinal Pathogenic Escherichia coli Collected From the Blood of Patients With Bacteremia Across Multiple Surveillance Studies. (10th June 2022)

Authors:
Weerdenburg, Eveline; Davies, Todd; Morrow, Brian; Zomer, Aldert L; Hermans, Peter; Go, Oscar; Spiessens, Bart; van den Hoven, Thijs; van Geet, Gunter; Aitabi, Moussa; DebRoy, Chitrita; Dudley, Edward G; Bonten, Marc; Poolman, Jan; Geurtsen, Jeroen
Journal:
Clinical infectious diseases
Issue:
Volume 76:Number 3(2023)
Page Start:
e1236
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial. Issue 7 (July 2018)

Authors:
Dreno, Brigitte; Thompson, John F; Smithers, Bernard Mark; Santinami, Mario; Jouary, Thomas; Gutzmer, Ralf; Levchenko, Evgeny; Rutkowski, Piotr; Grob, Jean-Jacques; Korovin, Sergii; Drucis, Kamil; Grange, Florent; Machet, Laurent; Hersey, Peter; Krajsova, Ivana; Testori, Alessandro; Conry, Robert...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 7(2018)
Page Start:
916
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo. Issue 3 (8th March 2022)

Authors:
Watson-Jones, Deborah; Kavunga-Membo, Hugo; Grais, Rebecca F; Ahuka, Steve; Roberts, Natalie; Edmunds, W John; Choi, Edward M; Roberts, Chrissy H; Edwards, Tansy; Camacho, Anton; Lees, Shelley; Leyssen, Maarten; Spiessens, Bart; Luhn, Kerstin; Douoguih, Macaya; Hatchett, Richard; Bausch, Daniel G...
Other Names:
author non-byline.; Watson-Jones Deborah author non-byline.; John Edmunds W author non-byline.; Choi Edward M author non-byline.; Roberts Chrissy H author non-byline.; Lees Shelley author non-byline.; Edwards Tansy author non-byline.; Manno Daniela author non-byline.; Smith Peter G author non-by...
Journal:
BMJ open
Issue:
Volume 12:Issue 3(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial. Issue 6 (June 2019)

Authors:
Frenck, Robert W; Ervin, John; Chu, Laurence; Abbanat, Darren; Spiessens, Bart; Go, Oscar; Haazen, Wouter; van den Dobbelsteen, Germie; Poolman, Jan; Thoelen, Stefan; Ibarra de Palacios, Patricia
Journal:
Lancet infectious diseases
Issue:
Volume 19:Issue 6(2019)
Page Start:
631
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗